MedTrace Logo

Sunnaas International Network´s Stroke Study

NCT01732679 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 230

Last updated 2017-04-25

No results posted yet for this study

Summary

A descriptive study of the stroke rehabilitation content in specialized clinics in seven countries: procedures for admission to rehabilitation, services available and provided to patients, as well as duration of the stay and discharge routines. An observational study of changes in regard to the physical function, quality of life and psycho-social factors in stroke patients before and after specialized rehabilitation

Conditions

  • Cerebral Stroke

Interventions

OTHER

rehabilitation

Description of specialized rehabilitation and Influence on activities, life satisfaction, psycho social aspects 6 and 12 months post discharge

Sponsors & Collaborators

  • China Rehabilitation Research Center

    collaborator OTHER_GOV

  • Sichuan 81 Rehabilitation Center, Chengdu

    collaborator UNKNOWN

  • NYU Langoon medical center; The Rusk Institute of Rehabilitation Medicine, New York

    collaborator UNKNOWN

  • City outpatient clinics №2,Petrozavodsk, Petrozavodsk

    collaborator OTHER

  • Sheba Medical Center

    collaborator OTHER_GOV

  • Al-Wafa Rehabilitation Hospital

    collaborator OTHER

  • Bethlehem Arab Society for Rehabilitation, Betlehem

    collaborator UNKNOWN

  • Sahlgrenska University Hospital

    collaborator OTHER

  • Sunnaas Rehabilitation Hospital

    lead OTHER

Principal Investigators

  • Johan K Stanghelle, PhD, MD · Sunnaas rehabilitation hospital, University of Oslo

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2014-12-31
Completion
2016-10-31

Countries

  • United States
  • China
  • Israel
  • Norway
  • Palestinian Territories
  • Russia
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01732679 on ClinicalTrials.gov